Like any medication, GLP-1 treatments can cause side effects. Most are mild and temporary. Here's an honest look at what's common, what's not, and how a good program manages them.
The most frequently reported GLP-1 side effects are gastrointestinal: nausea, reduced appetite, constipation, or mild stomach discomfort. In the major trials of FDA-approved semaglutide and tirzepatide, these were usually mild to moderate and occurred mostly while the dose was being increased.[1][2] These tend to appear in the early weeks, especially when the dose is being increased, and usually ease as your body adjusts.
Key point: Side effects are most common during titration (the dose-increase phase) and typically diminish over time. This is exactly why programs increase the dose gradually rather than starting high.
GLP-1 slows digestion, which is part of how it reduces appetite, but that same effect can cause early nausea. As your body adapts to each dose level, these sensations generally settle. Many people find that eating smaller, slower meals helps significantly in the early weeks.
Answer six quick questions and we'll match you to a LegitScript-certified, physician-led program suited to your situation.
Take the QuizA legitimate program monitors how you're doing and can adjust your dose, slow the titration, or offer guidance if side effects are bothersome. This is one of the biggest reasons to use a physician-supervised program rather than an unregulated seller, there's someone accountable for your care.
Important: If you ever experience severe or unusual symptoms, contact your provider or seek medical care. This guide is general education, not medical advice.
GLP-1 medications can have rarer, more serious side effects, which is precisely why a medical evaluation and ongoing physician oversight are required. Your provider reviews your health history to assess whether the treatment is appropriate for you.
Take the 60-second quiz and we'll match you to the LegitScript-certified program most likely to fit your needs.
Take the Quiz, 60 SecondsAbout these figures: The clinical trial results cited on this page reflect the safety and efficacy of the FDA-approved brand-name medications that were studied (such as Wegovy®, Zepbound® and Foundayo™), used alongside a reduced-calorie diet and physical activity under clinical-trial conditions. Compounded medications do not undergo FDA evaluation for safety or effectiveness and were not studied in these trials; their efficacy and safety profiles may differ from the brand-name medications studied. Individual results vary. This information is educational and is not medical advice.
Price changes, new program reviews, and plain-English GLP-1 updates, straight to your inbox. Independent, and never sponsored by the programs we review.
By joining, you agree to receive emails from GLP One Guide. Unsubscribe anytime. We never sell your email. See our Privacy Policy.